Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.
Sethi
Nitin K
NK
Torgovnick
Josh
J
Arsura
Edward
E
D000927:Anticonvulsants / Q000008:administration & dosage*; D015982:Bias; D002220:Carbamazepine / Q000008:administration & dosage*; D002986:Clinical Trials as Topic / Q000941:ethics / Q000592:standards; D016265:Conflict of Interest; D030881:Disclosure / Q000592:standards; D004345:Drug Industry / Q000941:ethics / Q000592:standards; D004827:Epilepsy / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D000077287:Levetiracetam; D009462:Neurology / Q000941:ethics / Q000592:standards; D009480:Neuropharmacology / Q000941:ethics / Q000592:standards; D010889:Piracetam / Q000008:administration & dosage / Q000031:analogs & derivatives*; D015203:Reproducibility of Results; D016896:Treatment Outcome
D000927:Anticonvulsants; D002220:Carbamazepine; D000077287:Levetiracetam; D010889:Piracetam